ZUZANA LACCA: Open Payments
NPI 1134864069 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 16 payments from 12 companies in 2025. Trend: 2023 $95 · 2024 $0 · 2025 $642
Food & beverage: $625Education: $17
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 2 | $217 |
| ABBVIE INC. | 1 | $123 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| Genmab U.S., Inc. | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| BeOne Medicines USA, Inc. | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| BTG International Inc. | 1 | $19 |
Products named: EPKINLY, Optune Gio, Optune Lua (NovoTTF-200T), KEYTRUDA, Trodelvy, AYVAKIT, TEVIMBRA, XPOVIO.
Industry payments across MD — which companies pay providers there.
